Kratom is an unique medicinal herb with pain relieving properties that function as an opiate substitute. So why is the FDA and the DEA trying to block people’s access to it by making it a Schedule 1 drug?
Huge interest in the medicinal potential of CBD has catalyzed a rebirth of industrial hemp in the U.S. But is hemp the best source of CBD?
Several Cannabis-related bills have been introduced by the U.S. Congress in the current 114th Session. Three of these relate specifically to CBD.
The owners of Medical Marijuana Inc. acquired it through fraud, former board members say in a state court suit: William Martin and David Tobias say the Hemp Deposit and Distribution Corp. and its president and founder, Michael Llamas, lied to them to acquire a controlling interest in MJNA.
Numerous commercial start-ups have jumped on the CBD bandwagon. But along with a growing awareness of CBD as a potential health aid there has been a proliferation of misconceptions.
How did it happen that a medical marijuana ballot initiative supported by almost 90% of Florida voters in the spring was defeated in November? Let us count the ways. “Our state is not providing the structure and safe access that we need to help our children. It is very frustrating.”
In early 2014, Project CBD assigned a writer to investigate and report on Medical Marijuana Inc., a penny stock umbrella company that markets “hemp oil” products infused with cannabidiol (CBD), a medicinal component of the cannabis plant.